ADMA Biologics, Inc. (ADMA)
Market: NASD |
Currency: USD
Address: 465 State Route 17
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Show more
📈 ADMA Biologics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$32.33
-
Upside/Downside from Analyst Target:
78.34%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
>500%
-
Net Income Growth Range (1Y):
>500%
-
Revenue Growth Range (1Y):
50-100%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ADMA Biologics, Inc.
| Date | Reported EPS |
|---|
| 2026-03-02 (estimated upcoming) | - |
| 2025-11-05 (estimated upcoming) | - |
| 2025-11-04 (estimated upcoming) | - |
| 2025-08-06 (estimated upcoming) | - |
| 2025-08-05 (estimated upcoming) | - |
| 2025-05-07 | - |
| 2025-05-06 | - |
| 2025-03-03 | 0.14 |
| 2025-02-25 | - |
| 2025-01-13 | - |
| 2024-11-07 | 0.15 |
| 2024-08-08 | 0.13 |
| 2024-08-07 | 0.13 |
| 2024-05-09 | 0.08 |
| 2024-05-08 | 0.08 |
| 2024-02-28 | -0.08 |
| 2024-02-27 | -0.08 |
| 2023-11-08 | 0.01 |
| 2023-11-07 | 0.01 |
| 2023-08-09 | -0.03 |
| 2023-08-08 | -0.03 |
| 2023-05-10 | -0.03 |
| 2023-05-09 | -0.03 |
| 2023-03-23 | -0.06 |
| 2023-03-22 | -0.06 |
| 2022-11-09 | -0.08 |
| 2022-11-08 | -0.08 |
| 2022-08-10 | -0.07 |
| 2022-08-09 | -0.07 |
| 2022-05-11 | -0.1 |
| 2022-05-10 | -0.1 |
| 2022-03-24 | -0.09 |
| 2022-03-23 | -0.09 |
| 2021-11-10 | -0.13 |
| 2021-11-09 | -0.13 |
| 2021-08-11 | -0.14 |
| 2021-08-10 | -0.14 |
| 2021-05-12 | -0.16 |
| 2021-05-11 | -0.16 |
| 2021-03-25 | -0.2 |
| 2021-03-24 | -0.2 |
| 2020-11-05 | -0.19 |
| 2020-11-04 | -0.19 |
| 2020-08-05 | -0.23 |
| 2020-08-04 | -0.23 |
| 2020-05-06 | -0.24 |
| 2020-05-05 | -0.24 |
| 2020-03-11 | -0.18 |
| 2019-11-05 | -0.19 |
| 2019-08-07 | -0.25 |
| 2019-05-07 | -0.32 |
| 2019-03-12 | -0.39 |
| 2018-11-07 | -0.33 |
| 2018-08-09 | -0.34 |
| 2018-05-13 | -0.39 |
| 2018-03-04 | -0.29 |
| 2017-11-02 | -0.58 |
| 2017-08-10 | -0.55 |
| 2017-05-11 | -0.51 |
| 2017-02-23 | -0.35 |
| 2016-11-09 | -0.34 |
| 2016-08-11 | -0.5 |
| 2016-05-12 | -0.43 |
| 2016-03-22 | -0.45 |
| 2015-11-09 | -0.48 |
| 2015-08-10 | -0.44 |
| 2015-05-11 | -0.37 |
| 2015-03-08 | -0.38 |
| 2014-11-09 | -0.36 |
| 2014-08-10 | -0.43 |
| 2014-05-11 | -0.64 |
| 2014-03-27 | -0.54 |
📰 Related News & Research
No related articles found for "adma biologics".
